Rebecca Aubrey Betensky, Ph.D.
This page shows the publications co-authored by Rebecca Betensky and Sushrut Waikar.
The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. J Am Soc Nephrol. 2018 08; 29(8):2213-2224.
Biomarker validation with an imperfect reference: Issues and bounds. Stat Methods Med Res. 2018 10; 27(10):2933-2945.
A Concept-Wide Association Study of Clinical Notes to Discover New Predictors of Kidney Failure. Clin J Am Soc Nephrol. 2016 12 07; 11(12):2150-2158.
Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1335-42.
Reductions in red blood cell 2,3-diphosphoglycerate concentration during continuous renal replacment therapy. Clin J Am Soc Nephrol. 2015 Jan 07; 10(1):74-9.
Imperfect gold standards for biomarker evaluation. Clin Trials. 2013 Oct; 10(5):696-700.
Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012 Jan; 23(1):13-21.
Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant. 2009 Nov; 24(11):3263-5.
Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014 Oct; 25(10):2177-86.
Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem. 2013 Dec; 59(12):1742-52.
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec; 1(3):200-8.
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008 Apr; 73(7):863-9.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.